Polyadenylated and deproteinized nuclear RNA precursors encoded by early region 2 of the adenovirus 2 genome are spliced in vitro by nuclear extracts prepared from MOPC-315 mouse myeloma cells.
INTRODUCTION
Since the existence of spliced adenovirus 2 (Ad2) messenger RNAs was first demonstrated, a large number of viral and eukaryotic protein-coding genes and also tRNAs and rRNAs have been shown to be split (for review see [1] [2] [3] [4] [5] [6] .
Structural studies of several vn_ vivo RNA precursor molecules have provided evidence that split genes are transcribed into colinear precursors from which the intervening sequences (sequences separating the exons) are removed by a cleavage-ligation reaction (splicing) (for review see 4, 5) .
Elucidation of the biochemical steps in splicing of mRNAs is undoubtedly of fundamental importance for the understanding of mRNA synthesis and regulation of gene expression. The study of enzymes and components involved in the splicing reaction requires j_n vitro cell-free systems which are able to splice accurately and efficiently mRNA precursors. Jji vitro transcription and splicing of viral (7) and human 8 globin RNA (8) in the whole cell extracts from HeLa cells was reported. However, the efficiency of the splicing reaction in both systems are extremely low.
Recently (9), we have presented evidence that splicing of purified adenovirus precursor mRNA occurs very efficiently in a whole cell extract prepared from MOPC-315 mouse myeloma cells. The mRNA precursor that we have used for the vn_ vitro splicing reaction is encoded by one of the four regions expressed at early times after Ad2 infection (10, 11) , early region 2 (E 2 ).
The polypeptide product of E 2 is a 72,000 dalton DNA-binding protein (12) (13) (14) . Eg mRNA is copied from the strand transcribed in the leftward direction (15, 16) . This mRNA consists of two exons (each approximately 70 nucleotides) transcribed from positions 75 and 68.5, respectively, spliced to 1700 nucleotide mRNA body encoded from positions 66.3-61.6 of the Ad2 genome (17) (18) (19) . Studies of pulse-labeled polyadenylated nuclear RNA revealed three major species (20, 21 intervening sequence has been excised (22) .
The experiments we have performed with purified and deproteinized E 2 mRNA precursors and MOPC-315 mouse myeloma whole cell extracts demonstrate excision of intervening sequences and ligation of leader transcripts to the mRNA body (9) . However, from these experiments we cannot conclude that the splicing has the same precision as occurs i _n vivo. In this report, we describe a nuclear extract that splices with a very high efficiency purified deproteinized and polyadenylated E 2 mRNA precursors that have been obtained from cultures early in adenovirus infection. The nucleotide sequence of the j_n vitro processed E 2 RNAs across the splice junctions is identical to that of the 2H v iv° E 2 cytoplasmic mRNA. Therefore, the nuclear extract prepared from MOPC-315 mouse myeloma cells is capable of efficient and accurate in vitro splicing of E 2 mRNA precursors.
MATERIALS AND METHODS
Cell culture, virus infection, and RNA preparation. Maintenance of KB (human) and MOPC-315 mouse myeloma cell suspension cultures, procedures for Ad2 infections, and isolation of nuclear and cytoplasmic RNA were performed as described (21) . Infections were performed in the presence of 25 yg/ml cycloheximide and harvested at 6 hr after infection. High molecular weight poly(A) + RNA precursors to be used as substrates for in. vitro incubations were highly purified by fractionation on three successive 15-30% sucrose gradient sedimentations as described previously (9, 23) .
Preparation of nuclear extracts with splicing activity. Nuclear extracts containing splicing activity were prepared as described previously (9) with the following modifications. Suspension cultures of MOPC-315 mouse myeloma cells were grown to a density of approximately 1.5 x 10^ cells per ml. Cells were harvested and resuspended in isotonic buffer (10 mM Tris-HCl, pH 7.9, 1 mM EDTA, 1 mM DTT, 75 mM (NH 4 ) 2 S0 4 ) containing 0.025% Nonidet P-40. After 3-5 minutes on ice, the nuclei were collected by centrifugation at 10,000 g. The pelleted nuclei were resuspended in hypotonic buffer (10 mM Tris-HCl, pH 7.9, 1 mM EDTA, 1 mM DTT) containing 1% Nonidet P-40. After incubation for 30 min on ice, the nuclei were homogenized by four strokes in a dounce, and adjusted dropwise to 0.25 M sucrose and 0.4 M ammonium sulfate. After this addition, the lysate was gently stirred for 30 minutes at 4°C. The extract was then centrifuged at 50,000 rpm for 1 hour in a Beckman 60 Ti rotor.
The supernatant was removed and reprecipitated by addition of solid ammonium sulfate (0.51 gm per ml of suspension). The precipitate was collected by centrifugation and stored at -70°C. The total protein in nuclear extracts obtained from 1.5 x 10^ MOPC-315 cells was 30-40 mg. To test the splicing activity of the post-nuclear fraction, the supernatant of the 10,000 g centrifugation was adjusted to 1% Nonidet P-40, 0.25 M sucrose, and precipitated by addition of solid ammonium sulfate as described above. The precipitated extracts were thawed and resuspended in incubation buffer (60 mM Tris-HCl, pH 7.5, 150 mM (NH 4 ) 2 S0 4 , 3 mM DTT, 20% sucrose).
This suspension was applied directly to a Bio-Gel P,, desalting column as described before (9) . The material eluted in the void volume of this column was used to direct processing of RNAs j_n vitro. Reactions were in a total volume of 150 ul containing 50 pi of extract (600 wg of protein, equivalent to 3 x 10 7 MOPC-315 cells), 0.5 mM each GTP, CTP, UTP, and ATP, 10 mM creatine phosphate, 100 ug/ml creatine kinase, 300 ug of total cytoplasmic RNA purified from KB cells, and 10 mM MgC^. Incubations were at 30°C for 50 minutes. Reactions were terminated and RNAs purified as described (9) .
Preparation of a primer DNA fragment. The Ad2 DNA fragment 59.5-70.7 cloned in pBR322 plasmid was linearized by digesting sequentially with restriction endonucleases EcoRI and Xhol (see Figure 1 ). The cleaved DNA was subsequently treated with calf intestinal phosphatase, 5'-end-labeled with T 4 polynucleotide kinase and -f32p ATP (24) , and subcleaved with Ball.
The o<: P-labeled 147 base pair primer fragment, extending from the Xhol to the Bal_I site and labeled at the Xho_I site (see Figure 1) , was isolated by electrophoresis in an 8% nondenaturing acrylamide gel. The DNA fragment was recovered from the gel slice as described (24) .
Hybridizations of DNA primer with RNAs. Hybridizations of the 32 P 5'-end-labeled 147 DNA primer (0.5 ug) with polyadenylated cytoplasmic mRNA purified from 9 x 10^ KB cells infected at early times with Ad2 or ji_n vitro E 2 processed RNAs (E 2 precursor RNAs purified from 6 x 10 9 KB infected cells) were performed as described (25) . After hybridization for 18 hr, nucleic acids were diluted 10-fold with 0.5 M KC1, 10 mM Tris-HCl, pH 7.5, and applied to an oligo dT-cellulose column (26) . Molecules composed of poly(A) terminal RNA and bound 32 P DNA were eluted with water and precipitated with ethanol. Sequencing by primer extension. Nucleotide sequencing by performing chain extensions with dideoxynucleotides (ddNTP's) was performed as described (27, 28) . Hybrids were dissolved in the reverse transcriptase buffer (50 mM Tris-HCl, pH 8.3, 0.1 M KC1, 10 mM MgCl 2 , and 1 mM DTT), divided into aliquots supplemented with one of the four ddNTP's (P-L Biochemicals) and deoxynucleotides (dNTP's) at 57 pM each, except for dATP at 28.5 y M. The following ratios were used: dATP/ddATP, 0.49; dCTP/ddCTP, 2; dGTP/ddGTP, 1; dTTP/ddTTP, 1.35. Reverse transcriptase reactions were carried out in a final volume of 70 ul for 15 minutes at 40°C using 22 units of AMV reverse transcriptase (Life Science). Subsequently, 20 pi of a solution containing 250 mM of all four deoxynucleotides in the reaction buffer was added, and the incubation was continued for an additional 10 minutes. The reactions were terminated by adding 10 pi of 1 M sodium hydroxide and then heated at 100°C for 5 min. The reactions were neutralized, phenol extracted, and precipitated with ethanol. The products were resuspended in formamide dye sample buffer for sequencing gels, and analyzed by electrophoresis on 85 cm x 17.5 cm x 0.04 cm sequence gels containing 6% acrylamide and 7 M urea. Electrophoresis was carried out for 18 hr at 2000 V (29, 30) .
RESULTS
Nuclear Extracts Convert E 7 Nuclear RNA Precursors to the Size of the Mature mRNA
To assay for JUT. vitro processing activity, we have utilized E 2 nuclear RNA precursors.
The E 2 polyadenylated nuclear RNA contains three large size classes (28S, 26S, and 23S) in addition to molecules the size of cytoplasmic 20S mRNA (Figure 1) .
The larger forms contain intervening High molecular weight nuclear po1y(A) + RNA precursors to be used as substrates for j _n_ vitro incubations were fractionated on three successive 15-30% sucrose gradient sedimentations (9, 23) . Fractions 28S in size and larger were pooled, subjected to electrophoresis on glyoxal/1.1% agarose gels, and transferred to nitrocellulose paper. The nick translated 59.5-70.7 Ad2 ONA fragment cloned in PBR322 (3 x 108 cpm/ug) was annealed to the immobilized RNA (42) . After hybridization, the s o trips were exposed to X-ray film with an intensifying screen for 48 hrs at -70°C.
Panel A: Blot hybridization of E 2 poly(A) + nuclear RNAs after successive fractionations on 15-30% sucrose gradient sedimentation. Lane 1: ribosomal 14c markers (1 x 10^ cpm).
Lane 5: high molecular weight poly(A) + nuclear RNA pooled from the first sucrose gradient (RNA purified from 6 x 10 7 infected cells). Lanes 2 and 3: nuclear RNA pooled from the second and third sucrose gradients (RNA purified from 6 x 10? infected cells). Lane 4: high molecular weight nuclear RNA from the third gradient incubated j_n vitro in incubation buffer at 30°C for 50 min in the absence of extract as described in the experimental procedure (RNA purified from 6 x 107 cells).
Panel B: Blot hybridization of E 2 poly(A) + nuclear RNA precursors after incubation with a nuclear extract prepared from MOPC-315 mouse myeloma cells.
Lane 1: ribosomal l^C markers (1 x 10 4 cpm). Lanes 2 and 3: high molecular weight poly(A) + nuclear RNAs purified by three successive sucrose gradient sedimentations after vn_ vitro incubation with the nuclear extract as described in the experimental procedure (lane 2: RNA purified from 6 x 107 infected cells, and lane 3:
RNA purified from 6 x 108 infected cells).
Materials and Methods). After incubation the RNA was selected by oligo(dT)-cellulose chromotography and fractionated on glyoxal agarose gel. Figure 2A (lane 4) showed that the major 28S and 26S RNA species remained intact as judged by their size distribution. When the E2 precursor RNA was incubated in the presence of nuclear extracts prepared from MOPC-315 mouse myeloma cells and aliquots equivalent to 6 x 10^ and 6 x 10^ infected cells assayed for RNA processing, two new bands of 23S and 20S RNA were generated ( Figure 2B, lanes 2 and 3) . As reported with the whole cell MOPC-315 extract (9) , approximately 80% of the E 2 precursor RNA, on a molar basis, was converted to a 20S species (Figure 2 , densitometry scan not shown).
The preparation of the extracts isolated from MOPC-315 mouse myeloma used in the present study differs from that previously reported (9) . This extract was prepared from the nuclear fraction of the MOPC-315 cell and was isolated in the presence of Nonidet P-40 detergent. In order to demonstrate that all the RNA processing components were present in the nuclear fraction, the 10,000 g supernatant of the extract utilized for the experiment shown in Figure 2B was assayed for processing activity (see Materials and Methods). After incubation with the post-nuclear fraction, the E-RNA precursors remained the same (data not shown), indicating that no major leakage of the processing activities occurred during fractionation.
Nucleotide Sequence of the Splice Junctions in the In Vitro Spliced Eo RNAs
In order to investigate the accuracy of the vn_ vitro splicing reaction at the nucleotide level, polyadenylated nuclear RNA was isolated from 6 x 10 KB cells at early times during Ad2 infection, and fractionated on sucrose gradients as described in the legend of Figure 2 . Since approximately 80% of the E2 precursor RNAs was converted U± vitro to a 20S species (Figure 2B ), the remainder of the E2 precursor RNAs may originate bands in a sequencing gel corresponding to the E2 intervening sequences.
To obtain Jjn vitro spliced RNAs 20S in size and free of precursor RNAs, the jjn_ vitro RNA products after incubation with the nuclear extract were fractionated on a 15-30% sucrose gradient. RNAs 20S in size were pooled and the nucleotide sequence of the splice junctions was determined by performing RNA-DNA primer extensions with reverse transcriptase in the presence of 2'-3' dideoxynucleoside triphosphates as specific chain terminators. For this study we have chosen a primer DNA fragment of 147 nucleotides, which hybridizes 13 nucleotides downstream from the splice junction between the 5'-end main E 2 mRNA body and the second RNA leader (Figures 1 and 4) . Sequencing of the splice junctions of E? RNA precursors processed in vitro. High molecular weight nuclear RNAs were purified from 6 x 109 KB cells as described in the legend of Figure 2 and incubated in the presence of a nuclear extract prepared from MOPC-315 cells. Aliquots were tested for in vitro processing ( Figure 2B ). The i _n vitro processed RNAs were then fractionated on a 15-30% sucrose gradient sedimentation, and fractions containing RNA 20S in size were pooled and precipitated. The nucleotide sequence of the splice junctions in the j_n vitro processed RNAs was determined by performing chain extensions with reverse transcriptase in the presence of 2'-3'-dideoxinucleoside triphosphates.
The 147 nucleodite JCho^I-BaJ^I DNA primer (Figures 1 and 4) labeled at the 5'-end Mu)I site was hybridized and extended as described in the Materials and Methods.
Panel A: Nucleotide sequence of the splice junctions in the j_n vivo cytoplasmic E2 mRNA. o Exposure to X-ray film with an intensifying screen was for 15 hrs at -7O°C.
Panel B: Nucleotide sequence of the splice junctions in the iji vitro processed 20S E2 RNA. Exposure to X-ray film with an intensifying screen was for 7 days at -70°C. A, C, G, and T denote the specific ddNTP inhibitor used in the reaction.
B denotes a reaction in the absence of ddNTP's inhibitors, M markers 0X174 DNA 5'-end labeled. 4) was isolated and hybridized to the in vitro processed E 2 20S RNAs. The hybrids were selected by oligo(dT)-cellulose chromatography and precipitated with ethanol. Subsequently, reverse transcription was carried out in the presence of dideoxynucleotides as described in the Materials and Methods. The nucleotide sequence of the splice junctions of the in_ vitro processed RNA 
DISCUSSION
We have shown that adenovirus E 2 precursor RNA was accurately and efficiently spliced in vitro by nuclear extracts prepared from MOPC-315 mouse myeloma cells.
The nucleotide sequence analysis of the j_n vitro Eg RNA products by the dideoxy chain termination method demonstrated unambiguous evidence that cleavage and ligation, of both leader sequences to the RNA body, have the same precision as occurs _i _n_ vivo. From these experiments, we conclude that all the components of the splicing apparatus necessary to recognize and splice E 2 RNAs are present in the nuclear extracts prepared from MOPC-315 cells.
For future studies and purification, the nuclear extract may be a valuable source of splicing activity.
The efficiency of splicing obtained with the nuclear extracts, 80% on a molar basis, was the same as reported previously with whole cell extracts (9) . One of the factors which may have contributed to obtaining the high efficiency of _i _n vitro splicing was the fact that we have used polyadenylated mRNA precursor isolated from cultures early in Ad2 infection.
This RNA appears to be the precursor to the 72K DNA binding protein mRNA (20, 21) . RNAs transcribed _i _n_ vitro by concentrated whole HeLa cell extracts were reported to be spliced in situ with only a very low efficiency, between 2 and 5% (7, 8) . Other investigators were not able to detect any splicing in very similar jji vitro systems (31) . The discrepancies in splicing efficiencies between the jjl vitro system reported here and the coupled j _n_ vitro transcription-splicing systems could be due to several factors.
The j _n_ vitro transcribed RNAs could lack sequences or nucleoside modifications for attaining similar structures to those found U± vivo and therefore may not be ideal substrates for the splicing apparatus. For example, specific transcription termination and polyadenylation do not occur in the available eukaryotic j _n_ vitro transcription systems (32, 33) . Alternatively, inactivation of an essential component for splicing or of proteins that organize the precursor RNA into mRNP' s in vivo may occur during preparation of the whole HeLa cell extracts. We are currently testing the ability of the nuclear MOPC-315 extracts to splice run-off RNAs which have been synthesized in j£ vitro transcription systems. Preliminary results suggest a low efficiency of in vitro splicing (unpublished data). Further experiments on this question are underway. Any manipulations to analyze the ui vitro splicing reaction requires relatively rapid and reasonable assays. We have previously utilized assays which required the purification of large amounts of nuclear RNA from infected cells. By using Northern blots, we were able to increase the sensitivity for detection of the UL vitro spliced RNAs. This assay will facilitate future characterization of the splicing activities and/or co-factors such as ribonucleoprotein particles containing small nuclear RNAs  (snRNP's) that have been implicated in splicing (34,35) . Development of J_n_ vitro splicing systems are crucial for the understanding of the biochemical steps in RNA processing. For example, major features of the reaction mechanism have been described for the splicing of yeast tRNA precursors (36-38) and the ribosomal RNA precursors of tetrahymena pigmentosa (39,40) . Hopefully, further experiments utilizing the jji vitro splicing system described here will help to unravel the biochemical steps in mRNA splicing.
